We are live on ! Find out more
NI

Nextech Invest Portfolio holdings

AUM $1.42B
1-Year Est. Return 304.47%
This Fund
S&P 500
This Quarter Est. Return
+12.15%
1 Year Est. Return
+304.47%
3 Year Est. Return
+631.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$240M
AUM Growth
-$11.8M
Cap. Flow
-$7.59M
Cap. Flow %
-3.17%
Top 10 Hldgs %
98.62%
Holding
14
New
–
Increased
2
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$16M
2
RLAY icon
Relay Therapeutics
RLAY
+$2.69M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$12M
2
BPMC
Blueprint Medicines
BPMC
+$8.25M
3
PMVP icon
PMV Pharmaceuticals
PMVP
+$6.08M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$38.5B
$105M 43.76%
4,839,529
+650,000
+16% +$16M
TYRA icon
2
Tyra Biosciences
TYRA
$1.85B
$40.5M 16.89%
2,518,582
– –
EQRX
3
DELISTED
EQRx, Inc. Common Stock
EQRX
$25.4M 10.61%
13,104,424
– –
KNTE
4
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$14.6M 6.08%
2,329,480
– –
CGEM icon
5
Cullinan Oncology
CGEM
$1.06B
$12.5M 5.21%
1,221,145
– –
SPRY icon
6
ARS Pharmaceuticals
SPRY
$579M
$12.4M 5.19%
1,910,029
– –
RLAY icon
7
Relay Therapeutics
RLAY
$4B
$10.3M 4.3%
625,485
+150,000
+32% +$2.69M
ARVN icon
8
Arvinas
ARVN
$530M
$7.85M 3.28%
287,251
– –
THRX
9
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$5.43M 2.27%
611,310
– –
PMVP icon
10
PMV Pharmaceuticals
PMVP
$57.1M
$2.49M 1.04%
521,284
-864,523
-62% -$6.08M
KRON
11
DELISTED
Kronos Bio
KRON
$2.12M 0.88%
1,451,537
– –
CCCC icon
12
C4 Therapeutics
CCCC
$389M
$1.18M 0.49%
375,857
– –
BPMC
13
DELISTED
Blueprint Medicines
BPMC
– –
-188,228
Closed -$8.25M
MRTX
14
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-263,914
Closed -$12M

Similar funds

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.43B AUM 9.81% 1-Year Est. Return
APCM
Alaska Permanent Capital Management Anchorage, Alaska $1.43B AUM 13.12% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Nextech Invest's Q1 2023 Portfolio in Review

As of Q1 2023, Nextech Invest held 14 positions worth $240M, down 4.7% from $251M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Nextech Invest withdrew a net $7.59M in Q1 2023, closing 2 positions and reducing 1 holding. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $12M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Nextech Invest added an estimated $16M to Revolution Medicines.

  • Nextech Invest added most to Revolution Medicines in Q1 2023, an estimated $16M increase.
  • Nextech Invest's biggest Q1 2023 reduction was PMV Pharmaceuticals, cutting an estimated $6.08M.
  • Nextech Invest fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2023, selling an estimated $12M.
  • Nextech Invest's ten largest holdings make up 99% of its $240M portfolio in Q1 2023.
  • Nextech Invest opened 0 new positions and closed 2 in Q1 2023.
  • Nextech Invest's portfolio value fell 4.7% quarter-over-quarter to $240M.

Based on Nextech Invest's 13F filing for Q1 2023, filed 12 May 2023.